NCT06750861View on ClinicalTrials.gov

QL1706 Plus Chemotherapy With AG Regime as First-line Treatment of Advanced PDAC

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 15, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Pancreatic Adenocarcinoma
Interventions
DRUG

QL1706

QL1706+AG

Trial Locations (1)

100021

National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

All Listed Sponsors
lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER